Cyclophosphamide for Injection USP: Presence of particulate matter
Last updated
Summary
Product
Cyclophosphamide for Injection USP
Issue
Health products - Product quality
What to do
Consult your healthcare provider for any health concerns.
Distribution
National
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot Number |
|---|---|---|---|---|---|
Marcan Pharmaceuticals Inc |
Cyclophosphamide for Injection USP |
DIN 02560216 |
Powder for Solution |
1000 mg/vial |
7Z10346A |
Issue
| Presence of particulate matter in affected lot. |
What you should do
- Consult your healthcare provider for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Healthcare establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
|
Marcan Pharmaceuticals Inc 2 Gurdwara Rd. Suite #400, Ottawa, ON K2E 1A2 |
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type I
Identification number
RA-82896
Get notified
Receive emails about new and updated recall and safety alerts.